Mathematics and Statistics, The University of Haripur, Haripur, Pakistan
Department of Statistics, GCU, Lahore, Pakistan.
BMJ Open. 2023 Aug 28;13(8):e068445. doi: 10.1136/bmjopen-2022-068445.
The purpose of this research was to determine the prevalence of diabetes and pre-diabetes in Sri Lanka.
Systematic review and meta-analysis.
MEDLINE (via PubMed), Web of Science, Sri Lankan Journals online and Google Scholar were searched for relevant articles published between January 1990 and June 2022 investigating the prevalence of pre-diabetes and diabetes in Sri Lanka.
Random effect meta-analyses were conducted to derive the pooled prevalence of pre-diabetes and diabetes and their 95% CIs. Heterogeneity was explored by subgroup and meta-regression analyses. Sensitivity analyses were used to evaluate the impact of any single study on the pooled estimates. Two authors screened articles, extracted data and evaluated the quality of selected studies.
A total of 479 articles were reviewed, and 15 studies (n=30 137 participants) were selected in the final analysis. The overall pooled prevalence of diabetes was 12.07% (95% CI, 8.71% to 15.89%; prediction interval: 1.28-31.35). The pooled pre-diabetes prevalence was 15.57% (95% CI, 9.45% to 22.88%; prediction interval: 0.02-49.87). The pooled type 2 diabetes prevalence was the highest in the latest period of 2011-2021 (17.25%) than in the period of 2000s (11.84%) and 1990s (5.62%).
The growing trend of diabetes and pre-diabetes over the last 30 years is alarming in Sri Lanka. The government of Sri Lanka needs to take steps to improve diabetes education, screening, diagnosis and treatment.
CRD42021288591.
本研究旨在确定斯里兰卡的糖尿病和糖尿病前期患病率。
系统评价和荟萃分析。
通过 PubMed 版 MEDLINE、Web of Science、斯里兰卡在线期刊和 Google Scholar 检索 1990 年 1 月至 2022 年 6 月期间发表的有关斯里兰卡糖尿病前期和糖尿病患病率的相关文章。
采用随机效应荟萃分析得出糖尿病前期和糖尿病的汇总患病率及其 95%置信区间。通过亚组和荟萃回归分析探讨异质性。敏感性分析用于评估任何单一研究对汇总估计值的影响。两位作者筛选文章、提取数据并评估入选研究的质量。
共审查了 479 篇文章,最终分析中选择了 15 项研究(n=30137 名参与者)。糖尿病的总体汇总患病率为 12.07%(95%置信区间,8.71%至 15.89%;预测区间:1.28-31.35)。糖尿病前期的汇总患病率为 15.57%(95%置信区间,9.45%至 22.88%;预测区间:0.02-49.87)。2011-2021 年最新期间的汇总 2 型糖尿病患病率最高(17.25%),而 2000 年代(11.84%)和 1990 年代(5.62%)期间的患病率较低。
在过去 30 年中,糖尿病和糖尿病前期的增长趋势令人担忧。斯里兰卡政府需要采取措施,改善糖尿病教育、筛查、诊断和治疗。
PROSPERO 注册号:CRD42021288591。